Advanced Oncotherapy plc – LSE:AVO.L

Advanced Oncotherapy stock price today

GBP 38
+36.25
+2071.43%
Financial Health
0
1
2
3
4
5
6
7
8
9

Advanced Oncotherapy stock price monthly change

-39.24%
month

Advanced Oncotherapy stock price quarterly change

-76.67%
quarter

Advanced Oncotherapy stock price yearly change

-91.67%
year

Advanced Oncotherapy key metrics

Market Cap
 9.49M
Enterprise value
 68.99M
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Advanced Oncotherapy stock price history

Advanced Oncotherapy stock forecast

Advanced Oncotherapy financial statements

Profit Margin

Advanced Oncotherapy plc (LSE:AVO.L): Profit margin
Dec 2020 0 -13.11M
Jun 2022 0 -15.87M
Dec 2022 0 0
Jun 2023 0 0
AVO.L income statement history

Debt to Assets

Advanced Oncotherapy plc (LSE:AVO.L): Debt to assets
Jun 2021 126157360 89.83M 71.21%
Dec 2021 141290713 79.92M 56.57%
Jun 2022 153172854 92.65M 60.49%
Jun 2023 0 0
AVO.L balance sheet history

Cash Flow

Advanced Oncotherapy plc (LSE:AVO.L): Cash Flow
Dec 2021 -20.14M -5.77M 29.41M
Jun 2022 -7.44M -5.15M 10.80M
Dec 2022 0 0 0
Jun 2023 0 0 0
AVO.L cash flow history

Advanced Oncotherapy alternative data

Advanced Oncotherapy
Employees

Advanced Oncotherapy plc (LSE:AVO.L): Employee count
Aug 2023 174
Sep 2023 174
Oct 2023 174
Nov 2023 174
Dec 2023 174
Jan 2024 174
Feb 2024 174
Mar 2024 174
Apr 2024 174
May 2024 174
Jun 2024 174
Jul 2024 174

Advanced Oncotherapy other data

Advanced Oncotherapy
Executives

Insider Compensation
Dr. Michael Jeffrey Sinclair (1943) Executive Chairman
 $288,770
Prof. Stephen Myers OBE (1947) Executive Director
 $267,510

Frequently Asked Questions (FAQ)

  • What's the price of Advanced Oncotherapy stock today?

    One share of Advanced Oncotherapy stock can currently be purchased for approximately $38.

  • When is Advanced Oncotherapy's next earnings date?

    Unfortunately, Advanced Oncotherapy's (AVO.L) next earnings date is currently unknown.

  • Does Advanced Oncotherapy pay dividends?

    No, Advanced Oncotherapy does not pay dividends.

  • How much money does Advanced Oncotherapy make?

    Advanced Oncotherapy has a market capitalization of 9.49M.

  • What is Advanced Oncotherapy's stock symbol?

    Advanced Oncotherapy plc is traded on the LSE under the ticker symbol "AVO.L".

  • What is Advanced Oncotherapy's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Advanced Oncotherapy?

    Shares of Advanced Oncotherapy can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Advanced Oncotherapy's key executives?

    Advanced Oncotherapy's management team includes the following people:

    • Dr. Michael Jeffrey Sinclair Executive Chairman(age: 82, pay: $288,770)
    • Prof. Stephen Myers OBE Executive Director(age: 78, pay: $267,510)

  • How many employees does Advanced Oncotherapy have?

    As Jul 2024, Advanced Oncotherapy employs 174 workers.

  • When Advanced Oncotherapy went public?

    Advanced Oncotherapy plc is publicly traded company for more then 19 years since IPO on 4 Aug 2006.

  • What is Advanced Oncotherapy's official website?

    The official website for Advanced Oncotherapy is avoplc.com.

  • How can i contact Advanced Oncotherapy?

    Advanced Oncotherapy can be reached via phone at +44 20 3617 8728.

Advanced Oncotherapy company profile:

Advanced Oncotherapy plc

avoplc.com
Exchange:

LSE

Full time employees:

174

Industry:

Medical - Devices

Sector:

Healthcare

Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

+44 20 3617 8728
4 Tenterden Street
London, W1S 1TE

:
ISIN: GB00BD6SX109
CUSIP: G0100K115